John Overdeck’s MaxCyte MXCT Stock Holding History

John Overdeck’s Portfolio MXCT Stock Details MXCT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.8M	Buy	1,462,941 +854,779	+141%	+$852K	﹤0.01%	3100
2026 Q1	$427K	Buy	608,162 +520,244	+592%	+$486K	﹤0.01%	3834
2025 Q4	$136K	Buy	+87,918	New	+$140K	﹤0.01%	3819
2024 Q3	–	Sell	-23,406	Closed	-$91.8K	–	3263
2024 Q2	$91.8K	Sell	23,406 -62,944	-73%	-$271K	﹤0.01%	2833
2024 Q1	$362K	Sell	86,350 -66,010	-43%	-$310K	﹤0.01%	2478
2023 Q4	$716K	Buy	+152,360	New	+$593K	﹤0.01%	2269
2023 Q3	–	Sell	-15,661	Closed	-$71.9K	–	3119
2023 Q2	$71.9K	Buy	+15,661	New	+$72K	﹤0.01%	2788
2022 Q3	–	Sell	-56,294	Closed	-$266K	–	2692
2022 Q2	$266K	Buy	56,294 +26,591	+90%	+$131K	﹤0.01%	2069
2022 Q1	$208K	Buy	29,703 +7,408	+33%	+$50.6K	﹤0.01%	2327
2021 Q4	$227K	Buy	22,295 +10,652	+91%	+$114K	﹤0.01%	3835
2021 Q3	$142K	Buy	+11,643	New	+$176K	﹤0.01%	4036

Other funds holding MXCT

CFM

Capricorn Fund Managers London, United Kingdom $1.27B AUM 70.17% 1-Year Est. Return

Vitruvian Partners London, United Kingdom $201M AUM 10.44% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Mudita Advisors London, United Kingdom $481M AUM 73.74% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

BFM

Brooklands Fund Management London, United Kingdom $128M AUM

BNP Paribas Asset Management Paris, France $99.8B AUM 45.22% 1-Year Est. Return

CCM

Cadian Capital Management New York $1.32B AUM 4.19% 1-Year Est. Return

PLC

Peapod Lane Capital Bedford Hills, New York $148M AUM 89.92% 1-Year Est. Return

John Overdeck's MXCT Position: Q2 2026 in Review

John Overdeck increased its MaxCyte (MXCT) stake by 141% in Q2 2026, buying an estimated $852K and bringing the position to 1,462,941 shares worth $1.8M. The position accounts for ﹤0.01% of the portfolio, ranked #3100.

John Overdeck first reported a position in MXCT in Q3 2021 and has held it in 11 quarters since. 123 funds tracked by Wall St. Rank hold MXCT as of Q2 2026.

John Overdeck held 1,462,941 shares of MaxCyte worth $1.8M as of Q2 2026.
John Overdeck bought 854,779 MaxCyte shares in Q2 2026, an estimated $852K.
MaxCyte made up ﹤0.01% of John Overdeck's portfolio in Q2 2026, its #3100 holding.
John Overdeck first reported a position in MaxCyte in Q3 2021 and has held it in 11 quarters since.
123 funds tracked by Wall St. Rank held MaxCyte as of Q2 2026.

Based on Two Sigma Investments's 13F filing for Q2 2026, filed 14 Aug 2026.